You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 6, June 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  This Month in Archives of Dermatology
 This Article
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

This Month in Archives of Dermatology

Arch Dermatol. 2004;140:655.

Ultrasound-Guided Injection of Polidocanol Microfoam in the Management of Venous Leg Ulcers

Venous leg ulceration affects 1% to 3% of the elderly population and represents a severe complication of lower-limb venous insufficiency. Therapeutic options focusing on reversing the effects of venous hypertension include compression therapy, wound care and debridement, and minimally invasive surgery. Low-cost and noninvasive therapeutic procedures are needed as alternative treatments. Cabrera et al undertook a retrospective analysis of 116 patients who underwent ultrasound-guided injection of polidocanol microfoam (UIPM) in the treatment of their venous leg ulcerations. The rationale for UIPM treatment was to selectively and progressively sclerose sources of incompetence and thus reduce venous incompetence in the involved limb. The use of UIPM was found to be highly effective in achieving ulcer healing, even in very elderly patients.

(SEE ARTICLE)


Vulvar Lichen Sclerosus

Lichen sclerosus (LS) is a chronic inflammatory dermatitis found predominantly in the anogenital area with long-term sequelae that include the potential development of squamous cell carcinoma. Potent topical steroids remain the mainstay of therapy, but it remains unclear whether such therapy may prevent malignant transformation in this condition. In this prospective study of 83 women with vulvar LS who were treated with potent topical steroids until complete clinical and histologic remission, Renaud-Vilmer et al demonstrate the long-term safety and efficacy of 0.05% clobetasol proprionate ointment in the treatment of vulvar LS, although the suggested protective effect against malignant transformation failed to reach the level of statistical significance.

(SEE ARTICLE)


Recalcitrant Symptomatic Vulvar Lichen Planus: Response to Topical Tacrolimus

Lichen planus is a mucocutaneous inflammatory disease that may affect the genital mucosa with a wide range of manifestations and cause significant discomfort. Management of this sometimes debilitating condition is challenging, and therapeutic options include corticosteroids, antifungal agents, retinoids, estrogens, cyclosporine, hydroxychloroquine, and dapsone. In this retrospective analysis of 16 patients, Byrd et al reviewed the response of vulvar lichen planus to topical tacrolimus, an agent that offered significant symptomatic relief in all but 1 of the patients studied.

(SEE ARTICLE)


Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis: Economic Analysis in a Randomized Controlled Comparison of Methotrexate and Cyclosporine

Psoriasis is a chronic inflammatory skin disease for which only remittent rather than curative therapies are available. For patients with moderate to severe psoriasis, methotrexate and cyclosporine represent the mainstays of systemic therapy. Decision making regarding choices between these 2 modalities may be informed by many factors, among which might be the total costs associated with treatment. In this cost-minimization analysis performed in the setting of a randomized controlled trial, Opmeer et al demonstrate that clinical outcomes and quality of life were comparable between the 2 therapeutic modalities and that despite considerable difference in the medication costs, total treatment costs after 1 year were also comparable. These data suggest that economic considerations are not likely decisive for individual patient decisions or for the development of guidelines for systemic therapy.

(SEE ARTICLE)


Activation of Autoimmunity Following Use of Immunostimulatory Herbal Supplements

Herbal supplements are widely used as natural promoters of good health, and many are touted for their immunomodulatory effects. As awareness grows regarding the prevalence of complementary medicine use, the adverse effects of these supplements has become more widely recognized. In this case series, Lee and Werth describe 3 patients whose autoimmune disease onset or flares correlated with ingestion of herbal supplements with immunostimulatory effects. The mechanism for this effect needs further study, although increased production of tumor necrosis factor {alpha} may play a role. These cases offer cautionary examples of how immunostimulatory herbal supplements may exacerbate preexisting autoimmune disease in persons genetically predisposed to such disorders.


Heliotrope rash in patient 3.


(SEE ARTICLE)

SECTION EDITOR: ROBIN L. TRAVERS, MD







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.